Literature DB >> 11934220

Primary aldosteronism.

Carlos E Fardella1, Lorena Mosso.   

Abstract

Primary aldosteronism is a potentially curable form of hypertension. Recent studies using the plasma aldosterone to plasma renin activity ratio as screening test in hypertensive populations have demonstrated a high prevalence of primary aldosteronism close to 10%. This frequency is clearly higher than the classically described when hypokalemia is used as the screening method. The most common subtypes of primary aldosteronism are idiopathic aldosteronism and aldosterone-producing adenoma. Other causes are glucocorticoid-remediable aldosteronism, unilateral or primary adrenal hyperplasia and adrenal carcinoma. The diagnosis of primary aldosteronism is advocated to confirm the autonomy of aldosterone secretion from the renin-angiotensin system and to differentiate the clinical subtypes of the disease. This article reviews the new data about prevalence, diagnosis criteria and describes the clinical, biochemical and genetic characteristics of the different subtypes of the disease. We also discuss the treatment, and the differential diagnosis with other hyper-mineralocorticoid states.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934220

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  6 in total

1.  Aldosterone reduces crypt colon permeability during low-sodium adaptation.

Authors:  M Moretó; E Cristià; A Pérez-Bosque; I Afzal-Ahmed; C Amat; R J Naftalin
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

Review 2.  New aspects on primary aldosteronism.

Authors:  Ulla Enberg; Cristina Volpe; Bertil Hamberger
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

Review 3.  A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.

Authors:  Hiroyuki Koshiyama; Takeshi Fujisawa; Naomitsu Kuwamura; Yoshio Nakamura; Hiroshi Kanamori; Emi Oida; Akira Hara; Takashi Suzuki; Hironobu Sasano
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

Review 4.  Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.

Authors:  Vincenzo Salpietro; Agata Polizzi; Gabriella Di Rosa; Anna Claudia Romeo; Valeria Dipasquale; Paolo Morabito; Valeria Chirico; Teresa Arrigo; Martino Ruggieri
Journal:  Int J Endocrinol       Date:  2014-09-03       Impact factor: 3.257

5.  Association of adrenal medullar and cortical nodular hyperplasia: a report of two cases with clinical and morpho-functional considerations.

Authors:  Gloria Valdés; Eric Roessler; Iván Salazar; Helmar Rosenberg; Carlos Fardella; Pedro Martínez; Alfredo Velasco; Soledad Velasco; Pilar Orellana
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

Review 6.  Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension.

Authors:  Natalia Muñoz-Durango; Cristóbal A Fuentes; Andrés E Castillo; Luis Martín González-Gómez; Andrea Vecchiola; Carlos E Fardella; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2016-06-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.